Michael G. Atieh

Michael G. Atieh joined Immatics' Board of Directors in July 2020

Mr. Atieh currently serves on the Board of Directors of Chubb Limited (NYSE: CB) where he is a member of the Risk & Finance Committee, and previously chaired the Audit Committee from 2012 to 2018. He is also Chairman of the Board of electroCore Inc. (NASDAQ: ECOR) and a member of the Board of Directors of Oyster Point Pharma (NASDAQ: OYST) where he chairs the Audit Committee. His previous Board experience was with Theravance Biopharma (NASDAQ: TBPH) from 2014 to 2015, where he was a member of the Audit Committee and OSI Pharmaceuticals where he served as Chairman of the Audit Committee from 2003 to 2005.